Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: First impressions from Alligator’s new CEO

In June 2021, Søren Bregenholt began his new role as CEO for Lund-based company Alligator Bioscience. The company is about to initiate a phase II trial with mitazalimab, and drug candidate ATOR-1017 is soon to follow. Other projects are also advancing, and BioStock had the opportunity to talk to Bregenholt about his first impressions and what he expects to achieve as CEO of Alligator.Read the full interview with Alligator Bioscience's CEO Søren Bregenholt at biostock.se: https://www.biostock.se/2021/07/first-impressions-from-alligators-new-ceo/ This is a press release from BioStock -

2cureX and University Hospital of Hamburg-Eppendorf present IndiTreat data at ESMO GI for early-stage Pancreatic Cancer

2cureX announces the presentation of the poster [P-288] “Individual Drug Screening and heterogeneity analysis of patient derived tumoroids – Roadmap to improving therapy in Pancreatic Cancer” at the 2021 ESMO World Congress on Gastrointestinal Cancer (ESMO GI) starting yesterday. The poster is presented jointly with the University Hospital of Hamburg - Eppendorf (UKE - Hamburg, Germany) as part of a collaboration to bring Functional Testing to Pancreatic Cancer.The poster confirms the feasibility of using Functional Testing on resected tissue samples coming from the primary tumor, opening

BioStock: 2021 represents beginning of new era for Fluicell

As we head into the summer, BioStock takes a look at Fluicell’s achievements so far this year. Standing out are the company’s launch of their latest product, Biozone 6, and its dive into the regenerative medicine field through its BioRej Advance programme. BioStock spoke with Fluicell’s CEO Victoire Viannay to get her thoughts on the company’s new direction and what milestones Fluicell has its sights on for the rest of 2021.Read the interview with Victoire Viannay at biostock.se: https://www.biostock.se/en/2021-represents-beginning-of-new-era-for-fluicell/ This is a press release from

Carbiotix evaluation of new production enzyme yields positive results

Carbiotix (publ) ("Carbiotix" or “the Company”) today announces that it has completed a comprehensive evaluation of a new production enzyme supplied by a potential strategic partner yielding positive results. The Company will now proceed with the GRAS Self Affirmation process.Carbiotix communicated at the end of Q1 2021 that it would undertake a comprehensive evaluation of a new production enzyme supplied by a leading global enzyme producer and potential strategic partner in Q2 2021. This enzyme had the potential to accelerate achieving FDA GRAS No Objection and EFSA Novel Foods status in

Today Australian hygiene company Asaleo Care becomes Essity

Hygiene and health company Essity has today finalized its acquisition of the remaining 63.8% of the shares in the Australian hygiene company Asaleo Care. Essity AustralAsia, which is the name of the regional unit going forward, will be consolidated into Essity’s accounts as of July 1[st ], 2021.“It is with great pleasure we today welcome our new colleagues in Australia, New Zealand and the Pacific Islands to Essity. Together we will continue to improve well-being through our leading products and solutions and facilitate the opportunity for profitable growth in this region”, says Magnus

Beijer Ref becomes the majority owner of Fenagy A/S

Beijer Ref has entered into an agreement to increase its holding in the Danish refrigeration technology company Fenagy A/S. With an investment of DKK 19 million, Beijer Ref expands its ownership to just over 50 percent and thus becomes the majority shareholder. The company will be included in the financial accounts as of July 1, 2021, and will have a minor impact on the company’s earnings and position. The investment gives Fenagy the financial conditions necessary to strengthen the organization and meet the needs of the market. Beijer Ref made its first investment in Fenagy in

Will Martin Assumes Role as President and Chief Executive Officer of IRRAS

Stockholm, July 1, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Will Martin has formally assumed the role of President and Chief Executive Officer (CEO), which comes as part of a planned succession process first announced in April 2021. Kleanthis G. Xanthopoulos, Ph.D., will step down as CEO and will remain on the Company’s Board of Directors. Will Martin joined IRRAS as Chief Commercial Officer in 2018. Prior to IRRAS, he most recently served as General Manager of the

Change in Konecranes Leadership Team

KONECRANES PLC STOCK EXCHANGE RELEASE July 1, 2021 at 9:30 EEST Change in Konecranes Leadership Team Timo Leskinen, SVP for Human Resources and a member of the Konecranes Leadership Team, has decided to leave the company and will take a position at another company. He will leave Konecranes on 30 September 2021. “Timo has been a highly valued member of our Konecranes Leadership Team during the past eight years. I want to thank Timo for all his contributions at Konecranes and wish him the best of luck in his future career”, says Rob Smith, President and CEO of Konecranes.

NALCO selects Metso Outotec to deliver bauxite grinding package to their Damanjodi Alumina Refinery

Metso Outotec Corporation’s press release on July 1, 2021, at 09:30 a.m. EESTMetso Outotec has been awarded a contract for the engineering and delivery of a bauxite grinding package to National Aluminium Company’s (NALCO) Damanjodi Alumina Refinery for their 5[th] stream expansion project in Odisha, India. Typically, the value of this type of an order is in the range of EUR 12-15 million. The order has been booked in Minerals’ Q2/2021 orders received.Metso Outotec’s delivery includes basic design of bauxite silos and engineering and supply of two ball mills with a capacity of 434 tph each,

Magnus Grönborg, new CEO for OXE Marine AB

Magnus Grönborg has today (1 July 2021) assumed the CEO position for OXE Marine AB (publ) (NASDAQ STO: OXE), (OTCQX: CMMCF).Magnus Grönborg succeeds Myron Mahendra who will assume the position of EVP Business Development, Sales and Marketing. Appointing Magnus Grönborg is part of the previously communicated move into the next phase of OXE Marine´s development, with third party production facilities in both Poland and the US, where the board of directors has resolved to reorganize the management team to optimize the Company’s ability to achieve its financial and operational targets.   “

Invitation to Epiroc’s results presentation for Q2 2021 on July 20

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and infrastructure industries, will publish its Q2 2021 results on Tuesday July 20 at approximately 11.30 CEST. A results presentation for investors, analysts and media will be held at 13.00 CEST.The report will be presented by President and CEO Helena Hedblom and CFO Anders Lindén. It will be held in English and begin with a short presentation of the report followed by a question-and-answer session. To join the presentation, either access the link here 

Mandatum Asset Management acquires Trevian’s fund business

Mandatum Asset Management has signed an agreement concerning the purchase of real estate fund management company Trevian Funds AIFM Ltd. In connection with the transaction, Trevian’s entire fund management business, including the personnel employed by the company, will transfer to Mandatum Asset Management.Trevian Funds AIFM is a Finnish privately owned real estate fund management company that currently manages two funds: Trevian Finland Properties I and Trevian Carbon Sink Real Estate I Ky. Established in 2017, Trevian Funds AIFM has more than EUR 300 million in assets under management.

Stora Enso completes co-determination negotiations at Kvarnsveden site concerning the closure of pulp and paper production

STORA ENSO OYJ INVESTOR NEWS 1 July 2021 at 09:30 EESTStora Enso has completed the co-determination negotiations concerning the closing down the pulp and paper production at its Kvarnsveden site in Sweden. The closure will take place by the end of the third quarter of 2021. In April 2021, Stora Enso announced a plan to permanently close down pulp and paper production at its Kvarnsveden site due to the declining paper market. As a result of the co-determination negotiations regarding the Kvarnsveden site, pulp and paper production will be closed permanently by the end of the third quarter

Valmet has completed the acquisitions of EWK Umwelttechnik and ECP Group to strengthen its environmental systems business

Valmet Oyj’s press release on July 1, 2021 at 9:30 a.m. EETValmet has completed the acquisition of EWK Umwelttechnik GmbH and ECP Group Oy following the agreements that were announced on June 10. EWK Umwelttechnik is a German company manufacturing and supplying air emission control systems and after-installation services. ECP Group is a manufacturer and maintainer of electrostatic precipitators (ESP), focusing on power plants and pulp and paper industry, in Finland. EWK Umwelttechnik and ECP Group will be included in Valmet’s financial reporting for the first time in Valmet’s third

Nightingale Health quarterly summary of achieved key milestones and reiteration of near-term business targets

Company Release1 July 2021 at 9:25 a.m. (Finnish time)After the commencement of trading ofin its series B shares on Nasdaq First North Growth Market in March 2021, Nightingale Health Oyj (“Nightingale”) has completed the following milestones during the quarter started in April 2021 and ended in June 2021: · In April 2021, Nightingale’s fully owned subsidiary received clinical laboratory certification in Japan. Receiving the clinical laboratory certification prepared Nightingale for commercial launch of its service in Japan. · In April 2021, Nightingale entered into a strategic

Gaming Innovation Group signs Pennsylvania platform agreement with partner PlayStar

Gaming Innovation Group Inc. (GiG) has signed a long-term agreement with current partner PlayStar Casino, for the provision of GiG’s iGaming platform technologies to power the brand’s expansion into the state of Pennsylvania. Building on the foundation of the initial partnership, PlayStar Casino will use GiG to power its casino's second US market entry. This second agreement between GiG and PlayStar Casino is based on a revenue share model and has a minimum duration of four years. PlayStar Casino is a privately owned company founded and operated by industry pioneer Joel Wikell (founder

XNK Therapeutics Reports First Patient Included in Phase II Study in Multiple Myeloma

July 1, 2021 XNK Therapeutics AB (“XNK”) today announced that the first patient has been included in a Phase II clinical study to treat patients with Multiple myeloma using XNK’s leading autologous natural killer (NK) cell-based candidate drug in combination with Sanofi’s anti-CD38 antibody Sarclisa (Isatuximab).“Having the first patient included in this clinical study is a key step in XNK’s development”, said Johan Liwing, CEO of XNK Therapeutics. “While our leading drug candidate is now entering into Phase II, we are in parallel dedicated to progressing our clinical development plan

Basware publishes Half Year Financial Report for January–June 2021 on Thursday, July 15, 2021

Basware Corporation, press release, July 1, 2021 at 9.00 a.m. EESTBasware Corporation publishes Half Year Financial Report for January 1–June 30, 2021 on Thursday, July 15, 2021 at 8.45 a.m. EEST. The report and presentation material will be available on the company’s investor website at investors.basware.com/en after publishing. Basware arranges a briefing for analysts and press, where CEO Klaus Andersen and CFO Martti Nurminen will comment on the events and financial performance of the past quarter. The results briefing can be followed via live webcast or teleconference. A recording of

Elisa: Half year financial report publication on 16 July 2021

ELISA CORPORATION INVESTOR NEWS 1 JULY 2021 AT 9:00 AMElisa will publish its Half year financial report from January–June 2021 on Friday 16 July 2021 at approximately 8:30 am EET (6:30 UK time). International conference call for analysts and investors will be held on the same day at 12:00 pm EET. Dial-in numbers for the conference call, PIN: 99277459# · FI: +358 981 710 310 · SE: +46 856 642 651 · UK: +44 333 300 0804 · US: +1 631 913 1422 Audiocast: https://elisa.videosync.fi/q2-2021 The presentations, and later recording of the audiocast, will be available on

Aker Solutions and AF Gruppen Join Forces to Create a Leading Global Offshore Decommissioning and Recycling Company

July 1, 2021 - Today, Aker Solutions and AF Gruppen have signed a Letter of Intent (LOI) to merge the two companies’ existing offshore decommissioning operations into a 50/50 owned company with the goal of creating a leading global player for environmentally friendly recycling of offshore assets. By establishing a pure, focused player dedicated to unleashing global decom potential, the parties will make a significant contribution towards a sustainable, green transition of the offshore sector."By combining Aker Solutions’ offshore, engineering and project execution capabilities with AF

H & M Hennes & Mauritz AB Six -month report

First half-year (1 December 2020 – 31 May 2021) · The H&M group’s net sales in local currencies increased by 12 percent in the first half of 2021 compared with the corresponding period last year. Converted into SEK the group’s net sales amounted to SEK 86,569 m (83,612). The pandemic led to reduced footfall as a result of continued restrictions and store closures. At the most, around 1,800 stores were temporarily closed, i.e. around 36 percent of the group’s total number of stores. · Profit after financial items increased to SEK 2,204 m (-3,978). The group’s profit after tax

Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update

Lund, Sweden July 1, 2021 Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2021 at 8:00 CET on July 15, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events &

Metso Outotec celebrates first anniversary with notable achievements and by building future sustainable business

Metso Outotec Corporation’s press release on July 1, 2021, at 09:00 a.m. EESTExactly a year ago, Metso and Outotec merged and created a new leader in the mining, aggregates and metals refining industries, making the most of the expertise that covers the full spectrum of products, services and solutions from ore bodies to metals. With over 15,000 employees, presence in over 50 countries and sales close to 4 billion euros in 2020, it is one of the largest in its field. All-embracing sustainability Metso Outotec’s strategy is characterized by a strong focus on sustainability and

OssDsign’s Management and Board of Directors increase their long-term commitment through acquisiton of warrants for a total amount of approximately SEK 1.3 million

Uppsala, Sweden, 08.00 CET, 1 July 2021 – OssDsign, a global provider of regenerative orthopedic solutions for treatment of patients who have suffered from cranial or spinal bone defects, today announces that its Management and Board of Directors have acquired 3.8m warrants under the 2021/2024 long-term incentive programme for a total amount of approximately SEK 1.3 million.The largest individual participants in the incentive programme are the company’s CEO, CFO and Chairman: · Morten Henneveld (CEO) has aquired 1,712,235 warrants at an approximate cost of SEK 600 000 · Anders

There are no items matching the current filter
There are no more items matching the current filter
Back to top